Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness

PHASE2CompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

January 25, 2022

Study Completion Date

February 9, 2022

Conditions
InfluenzaInfluenza -Like Illness
Interventions
DRUG

Norketotifen

Oral capsule

DRUG

Placebo

Oral capsule

Trial Locations (20)

15478

Frontier Clinical Research, Smithfield

15683

Frontier Clinical Research, Scottdale

21204

Continental Clinical Solutions, Towson

26505

Frontier Clinical Research, Morgantown

27549

Relief Integrated Health Care, Louisburg

29169

Clinovacare Medical Research Center, West Columbia

32713

Omega Research Debary, DeBary

33135

South Florida Research Center, Miami

33165

Premier Research Associate, Miami

33173

Research Institute of South Florida, Miami

34744

The Chappel Group Research, Kissimmee

38305

Clinical Research Solutions, Jackson

44130

Clinical Research Solutions, Middleburg Heights

57702

Health Concepts, Rapid City

70535

Horizon Research Group of Opelousas, Eunice

75251

Cedar Health Research, Dallas

77027

Advanced Medical Group, Houston

85032

Precision Trials AZ, Phoenix

89121

Clinical Research of South Nevada, Las Vegas

90017

Downtown LA Research Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Emergo Therapeutics, Inc.

INDUSTRY